- Conditions
- Idiopathic Pulmonary Fibrosis, Lung Diseases, Lung Diseases, Interstitial, +2 more
- Locations
-
- ULB Hôpital Erasme Brussels, Belgium
- Cliniques Universitaires St-Luc Brussels, Belgium
- UZ Antwerpen Edegem, Belgium
- UZ Leuven Gasthuisberg Leuven, Belgium
Clinical trial condition
Lung Diseases, Interstitial
Explore clinical trials studying Lung Diseases, Interstitial. Study availability and eligibility vary by location and protocol.
725 public trials
132 recruiting studies
Lung Diseases, Interstitial trial results
NCT03386994
- Conditions
- Idiopathic Pulmonary Fibrosis, Lung Diseases, Lung Diseases, Interstitial, +2 more
- Locations
-
- Hospital General Universitario de Alicante Alicante, Spain
- Hospital Infanta Cristina Badajoz, Spain
- Hospital Universitario Cruces Barakaldo (Vizcaya), Spain
- H. del Mar Barcelona, Spain
NCT02738801
- Conditions
- Idiopathic Pulmonary Fibrosis, Lung Diseases, Lung Diseases, Interstitial, +2 more
- Locations
-
- Municipal Clinical Hospital # 6 Dnipropetrovsk, Ukraine
- Kharkov City Clinical Hospital # 13 Kharkiv, Ukraine
- F.G. Yanovskyy Institute of Phthisiatry and Pulmonology 1 Kiev, Ukraine
- F.G. Yanovskyy Institute of Phthisiatry and Pulmonology 2 Kiev, Ukraine
NCT01587001
- Conditions
- Hemic and Lymphatic Diseases, Hypersensitivity, Hypersensitivity, Delayed, +9 more
- Locations
-
- National Jewish Health Denver, Colorado, United States
NCT01107028
- Conditions
- Dyspnea, Idiopathic Pulmonary Fibrosis, Lung Diseases, +7 more
- Locations
-
- National Jewish Health Denver, Colorado, United States
NCT02846324
- Conditions
- Hypoxemia, Hypoxia, Idiopathic Pulmonary Fibrosis, +7 more
- Locations
-
- Birmingham, Alabama, United States
- San Francisco, California, United States
- Denver, Colorado, United States
- Miami, Florida, United States
Completed
Breath Analysis in Lung Fibrosis
NCT02437448
- Conditions
- Idiopathic Lung Fibrosis, Idiopathic Pulmonary Fibrosis, Lung Diseases, +3 more
- Locations
-
- Pulmonary Division, University Hospital of Zurich Zurich, Switzerland
Completed
A Study to Test the Ability of and Safety of GSK2110183 in Treating Langerhans Cell Histiocytosis
NCT01395004
- Conditions
- Hemic and Lymphatic Diseases, Histiocytosis, Histiocytosis, Langerhans-Cell, +5 more
- Locations
-
- Johns Hopkins Hospital Baltimore, Maryland, United States
- Dana Farber Cancer Institute Boston, Massachusetts, United States
- Memorial Sloan Kettering Cancer Center New York, United States
- Staten Island University Hospital Staten Island, New York, United States
NCT03650075
- Conditions
- Idiopathic Pulmonary Fibrosis, Idiopathic Pulmonary Fibrosis (IPF), Lung Diseases, +3 more
- Locations
-
- Taipei Medical University Hospital Taipei, Taiwan
NCT03115619
- Conditions
- Idiopathic Pulmonary Fibrosis, Lung Diseases, Lung Diseases, Interstitial, +2 more
- Locations
-
- Sotiria Hospital for Diseases of the Chest, Academic Department of Pneumonology Athens, Greece
- University General Hospital of Athens "Attikon", B' University Pulmonary Clinic Chaïdári, Greece
- University General Hospital of Heraklio, Pulmonary Clinic Heraklio, Greece
- University General Hospital of Ioannina Ioannina, Greece